Tiwari, Shashi Kant
Dang, Jason W
Lin, Nianwei
Qin, Yue
Wang, Shaobo
Rana, Tariq M https://orcid.org/0000-0001-9558-5766
Funding for this research was provided by:
HHS | NIH | National Institute on Drug Abuse (DA039562)
HHS | NIH | National Institute on Drug Abuse (DA046171)
HHS | NIH | National Institute on Drug Abuse (DA049524)
Article History
Received: 28 August 2019
Revised: 7 September 2020
Accepted: 17 September 2020
First Online: 19 October 2020
Conflict of interest
: T.M.R. is a founder of ViRx Pharmaceuticals and has an equity interest in the company. The terms of this arrangement have been reviewed and approved by the University of California San Diego in accordance with its conflict of interest policies.